Clinical Trial: Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07588698) titled 'Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma' on May 07.

Brief Summary: A Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggressive B-cell non-Hodgkin lymphoma.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Non-Hodgkin's B-cell Lymphoma Lymphoma Non-Hodgkin Diffuse Large B-Cell Lymphoma (DLBCL)

Intervention: DRUG: Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone (R-CHOP)

Given orally and intravenously (IV)

DRUG: Epcoritamab

Given subcutaneo...